Baudolino Mussa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Baudolino Mussa has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Barbara Defrancisco
Surgical sciences, University of Turin, Turin, Italy, Italy
7 shared publications Barbara Defrancisco
Surgical Science Department, University of Turin, Turin, Italy
6 shared publications- Mario Morino
Surgical Science Department, University of Turin, 10124 Turin, Italy
4 shared publications - Carla Rognoni
Bocconi University
2 shared publications - Gloria Passarella
Surgical Science Department, University of Turin, 10124 Turin, Italy
2 shared publications - Kimberly Alsbrooks
Becton Dickinson and Co, Franklin Lakes, NJ, USA
2 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8203
Correction: Mussa et al. Single-Port Laparoscopy Compared with Conventional Laparoscopic Surgery: A Systematic Review and Meta-Analysis. J. Clin. Med. 2025, 14, 4915
There was an omission in the original publication
- 22 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8203
Open AccessCorrection: Mussa et al. Single-Port Laparoscopy Compared with Conventional Laparoscopic Surgery: A Systematic Review and Meta-Analysis. J. Clin. Med. 2025, 14, 4915
There was an omission in the original publication
- Open Access
- 25 May 2026
- Published by MDPI AG in Preprints.org
Living with a Stoma: A Systematic Review and Meta-Analysis of Quality-of-Life and Psychological Outcomes After Colostomy Versus Ileostomy
Background: Intestinal stomas affect an estimated 1.5 million people worldwide. The comparative psychosocial burden of colostomy versus ileostomy remains poorly synthesised, leaving clinicians without quantitative guidance for shared decision-making. Methods: PRISMA-2020-compliant systematic review and random-effects meta-analysis (DerSimonian–Laird) of studies published January 2000–March 2026 (PubMed/MEDLINE, Embase, Cochrane Library, PsycINFO). Of 47 studies in the systematic review (n = 38,612), 22 contributed extractable means ± SD to the quantitative meta-analysis. The SMD was coded as colostomy minus ileostomy on the respective scale: a positive SMD on symptom/burden scales (depression, body image disturbance) indicates greater burden in colostomy; a positive SMD on HRQoL scales (higher = better) indicates better HRQoL in colostomy. Subgroup analyses were prespecified for stoma duration (temporary vs. permanent) and indication (oncological, IBD, other). Publication bias was assessed with Egger’s test and trim-and-fill. Results: Colostomy patients had slightly better global HRQoL on disease-specific instruments than ileostomy patients (SMD = +0.12, 95% CI +0.03 to +0.21; I² = 46%), driven by output-related morbidity in ileostomy. However, colostomy patients experienced greater depressive symptoms (SMD = +0.42, 95% CI +0.10 to +0.74; I² = 8%), worse body image (SMD = +0.36, 95% CI +0.14 to +0.58; I² = 61%), and poorer sexual function, particularly after abdominoperineal resection (SMD = −0.48, 95% CI −0.71 to −0.25 on higher = better scales). Permanent stomas were associated with greater body image disturbance and poorer physical functioning than temporary stomas Conclusions: Colostomy and ileostomy produce comparable global HRQoL but distinct psychosocial signatures. Stoma type alone is a weaker determinant of HRQoL than duration, complications, sex, age, and indication. These findings should inform individualised counselling, stoma siting, and structured psychosocial follow-up programmes.
- 25 May 2026
- Published by MDPI AG in Preprints.org
Open AccessLiving with a Stoma: A Systematic Review and Meta-Analysis of Quality-of-Life and Psychological Outcomes After Colostomy Versus Ileostomy
Background: Intestinal stomas affect an estimated 1.5 million people worldwide. The comparative psychosocial burden of colostomy versus ileostomy remains poorly synthesised, leaving clinicians without quantitative guidance for shared decision-making. Methods: PRISMA-2020-compliant systematic review and random-effects meta-analysis (DerSimonian–Laird) of studies published January 2000–March 2026 (PubMed/MEDLINE, Embase, Cochrane Library, PsycINFO). Of 47 studies in the systematic review (n = 38,612), 22 contributed extractable means ± SD to the quantitative meta-analysis. The SMD was coded as colostomy minus ileostomy on the respective scale: a positive SMD on symptom/burden scales (depression, body image disturbance) indicates greater burden in colostomy; a positive SMD on HRQoL scales (higher = better) indicates better HRQoL in colostomy. Subgroup analyses were prespecified for stoma duration (temporary vs. permanent) and indication (oncological, IBD, other). Publication bias was assessed with Egger’s test and trim-and-fill. Results: Colostomy patients had slightly better global HRQoL on disease-specific instruments than ileostomy patients (SMD = +0.12, 95% CI +0.03 to +0.21; I² = 46%), driven by output-related morbidity in ileostomy. However, colostomy patients experienced greater depressive symptoms (SMD = +0.42, 95% CI +0.10 to +0.74; I² = 8%), worse body image (SMD = +0.36, 95% CI +0.14 to +0.58; I² = 61%), and poorer sexual function, particularly after abdominoperineal resection (SMD = −0.48, 95% CI −0.71 to −0.25 on higher = better scales). Permanent stomas were associated with greater body image disturbance and poorer physical functioning than temporary stomas Conclusions: Colostomy and ileostomy produce comparable global HRQoL but distinct psychosocial signatures. Stoma type alone is a weaker determinant of HRQoL than duration, complications, sex, age, and indication. These findings should inform individualised counselling, stoma siting, and structured psychosocial follow-up programmes.
- Open Access
- 25 May 2026
- Published by MDPI AG in Preprints.org
Infectious Complications of Peripheral Intravenous Catheters and Their Hematogenous Distant Sequelae: A Systematic Review and Meta-Analysis
Background: Peripheral intravenous catheters (PIVCs) are the most frequently inserted intravascular devices globally (~2 billion per year), yet their infectious complications—and particularly hematogenous distant infections—remain systematically underestimated and excluded from mainstream catheter-associated bloodstream infection (CABSI) surveillance. We present the first systematic review and meta-analysis specifically focused on hematogenous distant complications as the primary outcome. Methods: A systematic search of PubMed, EMBASE, CINAHL, and the Cochrane Library (no date restriction through April 2025) was conducted following PRISMA 2020 guidelines. Random-effects meta-analysis with Freeman–Tukey double-arcsine transformation was used for proportion outcomes; pooled incidence rates per catheter and per 1000 catheter-days were computed. Primary outcomes were infective endocarditis (IE), osteomyelitis, septic arthritis, epidural abscess, and septic emboli attributable to PIVC-related bacteremia. Results: Sixty-seven studies (n = 1,247,430 PIVCs; 2,547,841 catheter-days) met inclusion criteria. Pooled PIVC-BSI incidence was 0.028% per catheter (95% CI 0.009–0.081; I² = 96.8%) in high-income settings and 2.41/1000 catheter-days (95% CI 1.97–2.89) in low-/middle-income country ICUs. Among PIVC-related Staphylococcus aureus bacteremia (PIVC-SAB) episodes, the pooled metastatic complication rate was 37.2% (95% CI 24.1–51.6%; I² = 71.4%). IE developed in 6–23% of PIVC-SAB cases. Thirty-day all-cause mortality ranged from 12.9% to 25.0% overall; for S. aureus-specific cohorts it reached 18.3–26.5%. Dwell time > 96 h (OR 3.16, 95% CI 1.73–5.77), antecubital fossa insertion (OR 8.20, 95% CI 3.10–21.70), and large-bore gauge ≤16G (HR 4.65, 95% CI 1.19–18.20) were independently associated with PIVC-BSI in PIVC-specific multivariate analyses. Conclusions: PIVCs cause clinically severe hematogenous distant infections in approximately one-third of bacteremia episodes, with 30-day mortality equivalent to central venous catheter bloodstream infections. Current national surveillance systems that exclude PIVCs produce a critical undercount of catheter-attributable infections and deaths. Mandatory bundle-based PIVC care, inclusion of PIVCs in national BSI surveillance, and dedicated prospective studies quantifying the burden of hematogenous complications are urgently warranted.
- 25 May 2026
- Published by MDPI AG in Preprints.org
Open AccessInfectious Complications of Peripheral Intravenous Catheters and Their Hematogenous Distant Sequelae: A Systematic Review and Meta-Analysis
Background: Peripheral intravenous catheters (PIVCs) are the most frequently inserted intravascular devices globally (~2 billion per year), yet their infectious complications—and particularly hematogenous distant infections—remain systematically underestimated and excluded from mainstream catheter-associated bloodstream infection (CABSI) surveillance. We present the first systematic review and meta-analysis specifically focused on hematogenous distant complications as the primary outcome. Methods: A systematic search of PubMed, EMBASE, CINAHL, and the Cochrane Library (no date restriction through April 2025) was conducted following PRISMA 2020 guidelines. Random-effects meta-analysis with Freeman–Tukey double-arcsine transformation was used for proportion outcomes; pooled incidence rates per catheter and per 1000 catheter-days were computed. Primary outcomes were infective endocarditis (IE), osteomyelitis, septic arthritis, epidural abscess, and septic emboli attributable to PIVC-related bacteremia. Results: Sixty-seven studies (n = 1,247,430 PIVCs; 2,547,841 catheter-days) met inclusion criteria. Pooled PIVC-BSI incidence was 0.028% per catheter (95% CI 0.009–0.081; I² = 96.8%) in high-income settings and 2.41/1000 catheter-days (95% CI 1.97–2.89) in low-/middle-income country ICUs. Among PIVC-related Staphylococcus aureus bacteremia (PIVC-SAB) episodes, the pooled metastatic complication rate was 37.2% (95% CI 24.1–51.6%; I² = 71.4%). IE developed in 6–23% of PIVC-SAB cases. Thirty-day all-cause mortality ranged from 12.9% to 25.0% overall; for S. aureus-specific cohorts it reached 18.3–26.5%. Dwell time > 96 h (OR 3.16, 95% CI 1.73–5.77), antecubital fossa insertion (OR 8.20, 95% CI 3.10–21.70), and large-bore gauge ≤16G (HR 4.65, 95% CI 1.19–18.20) were independently associated with PIVC-BSI in PIVC-specific multivariate analyses. Conclusions: PIVCs cause clinically severe hematogenous distant infections in approximately one-third of bacteremia episodes, with 30-day mortality equivalent to central venous catheter bloodstream infections. Current national surveillance systems that exclude PIVCs produce a critical undercount of catheter-attributable infections and deaths. Mandatory bundle-based PIVC care, inclusion of PIVCs in national BSI surveillance, and dedicated prospective studies quantifying the burden of hematogenous complications are urgently warranted.
- Open Access
- 15 May 2026
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 30 (1)
Percutaneous ALPITube ileostomy for colorectal anastomotic protection: a multicentre feasibility study
Background: Standard loop ileostomy protects low colorectal anastomoses but causes substantial stoma-related morbidity including dehydration, high-output syndrome and metabolic complications. The Anastomotic Leak Prevention Ileostomy Tube (ALPITube) is a novel CE-marked percutaneous diversion device designed to provide anastomotic protection while avoiding traditional stoma complications. Objective: To evaluate the technical feasibility, safety profile and preliminary outcomes of ALPITube in an idea, development, exploration, assessment and long-term study (IDEAL) framework Stage 2a development study, with contextual comparison to published loop ileostomy benchmarks. Methods: Multicentre retrospective cohort study of consecutive patients undergoing elective colorectal surgery with low anastomosis and ALPITube diversion at two European centres – Clinica La Maddalena in Palermo, Italy ( n = 28), and Hospital HM Regla in León, Spain ( n = 15) – between May 2023 and June 2025. Primary outcome was 30-day complication rate. Secondary outcomes included device-specific adverse events, conversion to standard ileostomy and mortality. Results: Forty-three patients were analysed (mean age 69.7 ± 9.0 years; 88.4% with ≥ 1 comorbidity; 76.7% received neoadjuvant therapy). Device implantation was technically successful in all cases (mean implantation time 38 ± 14 min). Early complications occurred in 21 patients (48.8%), and were predominantly low-grade (Clavien–Dindo I–II: 25.6%). In total, five patients (11.6%) required conversion to loop ileostomy due to device maintenance difficulties. No anastomotic leaks or high-output syndrome occurred. No adverse events were associated with device removal. Contextual comparison with literature benchmarks suggested lower rates of high-output stoma (0% versus 16%), exit-site skin complications (18.6% versus 43%), postoperative ileus (4.7% versus 33%) and parastomal hernia (0% versus 8%). Conclusions: ALPITube demonstrates technical feasibility with an acceptable safety profile and signals potential reduction in stoma-specific complications. The 11.6% conversion rate reflects early implementation experience. These IDEAL Stage 2a findings support progression to prospective comparative studies.
- 15 May 2026
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 30 (1)
Open AccessPercutaneous ALPITube ileostomy for colorectal anastomotic protection: a multicentre feasibility study
Background: Standard loop ileostomy protects low colorectal anastomoses but causes substantial stoma-related morbidity including dehydration, high-output syndrome and metabolic complications. The Anastomotic Leak Prevention Ileostomy Tube (ALPITube) is a novel CE-marked percutaneous diversion device designed to provide anastomotic protection while avoiding traditional stoma complications. Objective: To evaluate the technical feasibility, safety profile and preliminary outcomes of ALPITube in an idea, development, exploration, assessment and long-term study (IDEAL) framework Stage 2a development study, with contextual comparison to published loop ileostomy benchmarks. Methods: Multicentre retrospective cohort study of consecutive patients undergoing elective colorectal surgery with low anastomosis and ALPITube diversion at two European centres – Clinica La Maddalena in Palermo, Italy ( n = 28), and Hospital HM Regla in León, Spain ( n = 15) – between May 2023 and June 2025. Primary outcome was 30-day complication rate. Secondary outcomes included device-specific adverse events, conversion to standard ileostomy and mortality. Results: Forty-three patients were analysed (mean age 69.7 ± 9.0 years; 88.4% with ≥ 1 comorbidity; 76.7% received neoadjuvant therapy). Device implantation was technically successful in all cases (mean implantation time 38 ± 14 min). Early complications occurred in 21 patients (48.8%), and were predominantly low-grade (Clavien–Dindo I–II: 25.6%). In total, five patients (11.6%) required conversion to loop ileostomy due to device maintenance difficulties. No anastomotic leaks or high-output syndrome occurred. No adverse events were associated with device removal. Contextual comparison with literature benchmarks suggested lower rates of high-output stoma (0% versus 16%), exit-site skin complications (18.6% versus 43%), postoperative ileus (4.7% versus 33%) and parastomal hernia (0% versus 8%). Conclusions: ALPITube demonstrates technical feasibility with an acceptable safety profile and signals potential reduction in stoma-specific complications. The 11.6% conversion rate reflects early implementation experience. These IDEAL Stage 2a findings support progression to prospective comparative studies.
- Open Access
- 8 May 2026
- Published by Wolters Kluwer Health in Journal of Infusion Nursing
- Vol. 49 (3) , 162-170
Peripheral Intravenous Catheter Complications: A Comparative Analysis of 6 Reference Documents
Objective: The objective of this study was to analyze current evidence-based pan-European standards of good clinical practice in the use of peripheral intravenous catheters (PIVCs) to determine if they meet clinicians’ needs for unambiguous, standardized guidance for the prevention and management of PIVC-associated complications. Methods: Reference documents meeting agreed inclusion criteria were identified and analyzed. Documents were systematically searched for terms (selected based on expertise of the authors and supported by scientific literature) most likely to be associated with the prevention/management of complications associated with the use of PIVCs. A matrix was constructed to visualize the degree of consensus across guidelines regarding prevention and management terminology. Recommendations for optimizing clarity and standardization across Europe were proposed. Results: Few European reference documents included PIVCs within their scope, and few were subject to a quality review. Adherence to the established GRADE framework of rating supporting evidence was missing from all reference documents. There was ambiguous terminology across documents and many instances of omission of terms rated important by the authors for the prevention and management of complications. Conclusion: An English-language European guideline for the prevention of complications associated with PIVCs is needed, featuring consensus terminology and a standardized, systematic, and transparent method for grading evidence.
- 8 May 2026
- Published by Wolters Kluwer Health in Journal of Infusion Nursing
- Vol. 49 (3) , 162-170
Open AccessPeripheral Intravenous Catheter Complications: A Comparative Analysis of 6 Reference Documents
Objective: The objective of this study was to analyze current evidence-based pan-European standards of good clinical practice in the use of peripheral intravenous catheters (PIVCs) to determine if they meet clinicians’ needs for unambiguous, standardized guidance for the prevention and management of PIVC-associated complications. Methods: Reference documents meeting agreed inclusion criteria were identified and analyzed. Documents were systematically searched for terms (selected based on expertise of the authors and supported by scientific literature) most likely to be associated with the prevention/management of complications associated with the use of PIVCs. A matrix was constructed to visualize the degree of consensus across guidelines regarding prevention and management terminology. Recommendations for optimizing clarity and standardization across Europe were proposed. Results: Few European reference documents included PIVCs within their scope, and few were subject to a quality review. Adherence to the established GRADE framework of rating supporting evidence was missing from all reference documents. There was ambiguous terminology across documents and many instances of omission of terms rated important by the authors for the prevention and management of complications. Conclusion: An English-language European guideline for the prevention of complications associated with PIVCs is needed, featuring consensus terminology and a standardized, systematic, and transparent method for grading evidence.
- Open Access
Strategies to Address Difficult Venous Access in Blood Sampling: A Comprehensive Meta-Analysis
Background and Objectives: Difficult venous access (DVA) affects 10–26% of hospitalized patients and up to 60% in high-risk populations, leading to increased patient discomfort, delayed diagnosis, and substantial healthcare costs estimated at $4.7 billion annually in the United States. This meta-analysis aimed to systematically evaluate the effectiveness, safety, and implementation considerations of traditional and emerging strategies for obtaining blood samples in patients with DVA. Materials and Methods: We conducted a comprehensive systematic review and meta-analysis following PRISMA guidelines. We searched MEDLINE, Embase, CINAHL, and Cochrane databases from January 2016 to December 2023. Inclusion criteria encompassed randomized controlled trials, systematic reviews, and observational studies examining DVA interventions in adult and pediatric populations. Primary outcomes included first-attempt success rates, overall success rates, and complication rates. Statistical analysis used random-effects models with risk ratios and 95% confidence intervals. Results: Forty-seven studies involving 12,847 patients met the inclusion criteria. Technology-assisted approaches demonstrated superior outcomes compared to traditional techniques. Ultrasound guidance showed the highest effectiveness with a first-attempt success increase of 42% (RR 1.42, 95% CI 1.26–1.58, p < 0.001), followed by near-infrared visualization with a 28% increase (RR 1.28, 95% CI 1.14–1.42, p < 0.001). Population-specific approaches yielded significant benefits, including the use of scalp veins for infants and external jugular approaches for extreme DVA cases. Cost-effectiveness analysis revealed that ultrasound guidance achieved break-even within 8–14 months in high-volume centers. Conclusions: A systematic, stepwise approach integrating appropriate technology and techniques significantly improves success rates while reducing patient discomfort and healthcare costs. Healthcare institutions should implement comprehensive DVA protocols with adequate training, equipment access, and quality monitoring. The proposed algorithm achieved a 93% overall success rate in validation studies, representing a substantial improvement over traditional approaches.
Open AccessStrategies to Address Difficult Venous Access in Blood Sampling: A Comprehensive Meta-Analysis
Background and Objectives: Difficult venous access (DVA) affects 10–26% of hospitalized patients and up to 60% in high-risk populations, leading to increased patient discomfort, delayed diagnosis, and substantial healthcare costs estimated at $4.7 billion annually in the United States. This meta-analysis aimed to systematically evaluate the effectiveness, safety, and implementation considerations of traditional and emerging strategies for obtaining blood samples in patients with DVA. Materials and Methods: We conducted a comprehensive systematic review and meta-analysis following PRISMA guidelines. We searched MEDLINE, Embase, CINAHL, and Cochrane databases from January 2016 to December 2023. Inclusion criteria encompassed randomized controlled trials, systematic reviews, and observational studies examining DVA interventions in adult and pediatric populations. Primary outcomes included first-attempt success rates, overall success rates, and complication rates. Statistical analysis used random-effects models with risk ratios and 95% confidence intervals. Results: Forty-seven studies involving 12,847 patients met the inclusion criteria. Technology-assisted approaches demonstrated superior outcomes compared to traditional techniques. Ultrasound guidance showed the highest effectiveness with a first-attempt success increase of 42% (RR 1.42, 95% CI 1.26–1.58, p < 0.001), followed by near-infrared visualization with a 28% increase (RR 1.28, 95% CI 1.14–1.42, p < 0.001). Population-specific approaches yielded significant benefits, including the use of scalp veins for infants and external jugular approaches for extreme DVA cases. Cost-effectiveness analysis revealed that ultrasound guidance achieved break-even within 8–14 months in high-volume centers. Conclusions: A systematic, stepwise approach integrating appropriate technology and techniques significantly improves success rates while reducing patient discomfort and healthcare costs. Healthcare institutions should implement comprehensive DVA protocols with adequate training, equipment access, and quality monitoring. The proposed algorithm achieved a 93% overall success rate in validation studies, representing a substantial improvement over traditional approaches.
- Open Access
- 10 February 2026
- Published by Taylor & Francis in Expert Review of Medical Devices
- Vol. 23 (3) , 335-347
Totally implanted ports and peripherally inserted central catheters for chemotherapy: a systematic review and meta-analysis of clinical outcomes and economic evaluations
Chemotherapy, while effective, can damage blood vessels due to repeated punctures and drug irritants, leading to complications like tissue damage from infiltration, clots, and phlebitis. To reduce these risks and improve patient comfort, venous catheters such as centrally inserted access ports (PORTs) and peripherally inserted central catheters (PICCs) are commonly used. This study systematically reviewed and analyzed clinical and economic data comparing PORTs and PICCs in adult chemotherapy patients, considering randomized trials, observational studies, and cost-effectiveness analyses. Data on complications and costs were extracted, and meta-analyses were conducted. Risk of bias was also assessed. Sixty-three studies were included. PORTs showed significantly lower rates (per 1000 catheter-days) of thrombosis, local infections, and catheter malposition compared to PICCs. Similar trends were seen for wound complications and mechanical issues. Economic analyses favored PORTs for cost-effectiveness. Study limitations included heterogeneity and potential bias, though overall quality was moderate to good. Findings support the clinical and economic value of PORTs for long-term chemotherapy, difficult venous access, and low-maintenance needs, whereas PICCs suit shorter treatment durations, patients unsuitable for minor surgery, or settings favoring bedside insertion. Decisions should align with the goals of the European Health Technology Assessment Regulation to harmonize medical device evaluation across Europe.
- 10 February 2026
- Published by Taylor & Francis in Expert Review of Medical Devices
- Vol. 23 (3) , 335-347
Open AccessTotally implanted ports and peripherally inserted central catheters for chemotherapy: a systematic review and meta-analysis of clinical outcomes and economic evaluations
Chemotherapy, while effective, can damage blood vessels due to repeated punctures and drug irritants, leading to complications like tissue damage from infiltration, clots, and phlebitis. To reduce these risks and improve patient comfort, venous catheters such as centrally inserted access ports (PORTs) and peripherally inserted central catheters (PICCs) are commonly used. This study systematically reviewed and analyzed clinical and economic data comparing PORTs and PICCs in adult chemotherapy patients, considering randomized trials, observational studies, and cost-effectiveness analyses. Data on complications and costs were extracted, and meta-analyses were conducted. Risk of bias was also assessed. Sixty-three studies were included. PORTs showed significantly lower rates (per 1000 catheter-days) of thrombosis, local infections, and catheter malposition compared to PICCs. Similar trends were seen for wound complications and mechanical issues. Economic analyses favored PORTs for cost-effectiveness. Study limitations included heterogeneity and potential bias, though overall quality was moderate to good. Findings support the clinical and economic value of PORTs for long-term chemotherapy, difficult venous access, and low-maintenance needs, whereas PICCs suit shorter treatment durations, patients unsuitable for minor surgery, or settings favoring bedside insertion. Decisions should align with the goals of the European Health Technology Assessment Regulation to harmonize medical device evaluation across Europe.
- Open Access
- 19 July 2025
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 32 (4)
Performance and safety of PowerGlide Pro® extended dwell peripheral catheters in an emergency medicine unit: A prospective observational study
Background: The increasing complexity of hospital care has led to a growing need for reliable vascular access devices. Extended dwell peripheral (EDP) catheters have emerged as potential options for intermediate‐term vascular access.Objective: To evaluate the performance, safety, and efficacy of the PowerGlide Pro® EDP catheter in a high‐dependency care setting within an emergency medicine unit.Methods: A prospective observational study was conducted on 300 patients with an anticipated need for intravenous therapy ≥7 days in an emergency medicine unit in Turin, Italy, from December 2019 to October 2020. Data collection included insertion success, complications, duration of use, and removal reasons. No control group was included. Complication rates were calculated both as raw percentages and as events per 1000 catheter‐days to facilitate comparison with existing literature.Results: Of 300 attempted placements, 283 (94.3%) were successful. First‐attempt success rate was 91.5%. Overall complication rate was 8.1% (n = 23) or 11.2 per 1000 catheter‐days, with 4.2% (n = 12) or 5.8 per 1000 catheter‐days resulting in device removal. Mean duration of catheter use was 7.26 ± 5.51 days (range: 1–31 days). Age >70 years (p = 0.014) and choice of insertion vein (p = 0.005) were significantly associated with higher complication rates.Conclusion: In this single‐center observational study, the PowerGlide Pro® EDP catheter demonstrated a high insertion success rate and relatively low complication rate. These findings suggest potential utility for intermediate‐term vascular access, though comparative studies are needed to definitively establish its advantages over other vascular access devices.
- 19 July 2025
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 32 (4)
Open AccessPerformance and safety of PowerGlide Pro® extended dwell peripheral catheters in an emergency medicine unit: A prospective observational study
Background: The increasing complexity of hospital care has led to a growing need for reliable vascular access devices. Extended dwell peripheral (EDP) catheters have emerged as potential options for intermediate‐term vascular access.Objective: To evaluate the performance, safety, and efficacy of the PowerGlide Pro® EDP catheter in a high‐dependency care setting within an emergency medicine unit.Methods: A prospective observational study was conducted on 300 patients with an anticipated need for intravenous therapy ≥7 days in an emergency medicine unit in Turin, Italy, from December 2019 to October 2020. Data collection included insertion success, complications, duration of use, and removal reasons. No control group was included. Complication rates were calculated both as raw percentages and as events per 1000 catheter‐days to facilitate comparison with existing literature.Results: Of 300 attempted placements, 283 (94.3%) were successful. First‐attempt success rate was 91.5%. Overall complication rate was 8.1% (n = 23) or 11.2 per 1000 catheter‐days, with 4.2% (n = 12) or 5.8 per 1000 catheter‐days resulting in device removal. Mean duration of catheter use was 7.26 ± 5.51 days (range: 1–31 days). Age >70 years (p = 0.014) and choice of insertion vein (p = 0.005) were significantly associated with higher complication rates.Conclusion: In this single‐center observational study, the PowerGlide Pro® EDP catheter demonstrated a high insertion success rate and relatively low complication rate. These findings suggest potential utility for intermediate‐term vascular access, though comparative studies are needed to definitively establish its advantages over other vascular access devices.